Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacogenetics of P2Y12 receptor inhibitors. | Pharmacotherapy | 2023 | 36588476 | PubTator, text mining | PubMed |
| Steady-State Pharmacokinetics of Intravenous Hydromorphone in Japanese Patients With Renal Impairment and Cancer Pain. | J Palliat Med | 2023 | 36579915 | PubTator, text mining | PubMed |
| Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma. | Mol Cell Biochem | 2023 | 36571650 | PubTator, text mining | PubMed |
| Verifying in vitro-determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically-based pharmacokinetic modeling. | CPT Pharmacometrics Syst Pharmacol | 2023 | 36540909 | PubTator, text mining | PubMed |
| Recurrent repeat expansions in human cancer genomes. | Nature | 2023 | 36517591 | PubTator, text mining | PubMed |
| Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes. | Toxicol In Vitro | 2023 | 36473578 | PubTator, text mining | PubMed |
| Quantification of Accurate Composition and Total Abundance of Homologous Proteins by Conserved-Plus-Surrogate Peptide Approach: Quantification of UDP Glucuronosyltransferases in Human Tissues. | Drug Metab Dispos | 2023 | 36446609 | PubTator, text mining | PubMed |
| Effect of ANKK1 Polymorphisms on Serum Valproic Acid Concentration in Chinese Han Adult Patients in the Early Postoperative Period. | Neurol Ther | 2023 | 36401149 | PubTator, text mining | PubMed |
| Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life. | CPT Pharmacometrics Syst Pharmacol | 2023 | 36309972 | PubTator, text mining | PubMed |
| Another Step Toward Qualification of Pediatric Physiologically Based Pharmacokinetic Models to Facilitate Inclusivity and Diversity in Pediatric Clinical Studies. | Clin Pharmacol Ther | 2023 | 36306419 | PubTator, text mining | PubMed |
| Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers. | Cancer Epidemiol Biomarkers Prev | 2023 | 36252563 | PubTator, text mining | PubMed |
| Diverse effects of α-/β-estradiol on catalytic activities of human UDP-glucuronosyltransferases (UGT). | J Steroid Biochem Mol Biol | 2023 | 36181991 | PubTator, text mining | PubMed |
| A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study. | Cancer Immunol Immunother | 2023 | 36083313 | PubTator, text mining | PubMed |
| Pharmacogenetics of Antiplatelet Therapy. | Annu Rev Pharmacol Toxicol | 2023 | 35914768 | PubTator, text mining | PubMed |
| Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients. | Eur J Hosp Pharm | 2023 | 35787526 | PubTator, text mining | PubMed |
Direct transcriptomic comparison of xenobiotic metabolism and toxicity pathway induction of airway epithelium models at an air-liquid interface generated from induced pluripotent stem cells and primary bronchial epithelial cells. | Cell Biol Toxicol | 2023 | 35641671 | PubTator, text mining | PubMed |
| Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH). | Clin Pharmacol Ther | 2023 | 35429164 | PubTator, text mining | PubMed |
| Metabolism-involved drug interactions with traditional Chinese medicines in cardiovascular diseases. | J Food Drug Anal | 2022 | 39666289 | PubTator, text mining | PubMed |
| Anti-inflammatory and arthritic activity of zaltoprofen compared to piroxicam in murine models. | Bioinformation | 2022 | 37426507 | PubTator, text mining | PubMed |
| Mechanism of crocin I on ANIT-induced intrahepatic cholestasis by combined metabolomics and transcriptomics. | Front Pharmacol | 2022 | 36744213 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=15